APA (7th ed.) Citation

FJ, H., CC, W., CL, H., SC, W., JC, G., CH, C., . . . YC, T. (2026). Site-specific differences in Nectin-4 expression and associated immune contexture in advanced urothelial carcinoma: Implications for Nectin-4-targeted ADCs. Therapeutic advances in medical oncology, 18, 17588359261463147. https://doi.org/10.1177/17588359261463147

Chicago Style (17th ed.) Citation

FJ, Hsueh, Wang CC, Hsu CL, Wu SC, Guo JC, Chuang CH, Chueh SC, and Tsai YC. "Site-specific Differences in Nectin-4 Expression and Associated Immune Contexture in Advanced Urothelial Carcinoma: Implications for Nectin-4-targeted ADCs." Therapeutic Advances in Medical Oncology 18 (2026): 17588359261463147. https://doi.org/10.1177/17588359261463147.

MLA (9th ed.) Citation

FJ, Hsueh, et al. "Site-specific Differences in Nectin-4 Expression and Associated Immune Contexture in Advanced Urothelial Carcinoma: Implications for Nectin-4-targeted ADCs." Therapeutic Advances in Medical Oncology, vol. 18, 2026, p. 17588359261463147, https://doi.org/10.1177/17588359261463147.